STOCK TITAN

State Street Corporation (CDNA) discloses 5.3% beneficial ownership stake in CareDx

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

State Street Corporation has filed a Schedule 13G reporting a passive ownership stake in CareDx, Inc. (CDNA). As of 12/31/2025, State Street reports beneficial ownership of 2,737,752 shares of CareDx common stock, representing 5.3% of the outstanding class.

State Street reports shared voting power over 2,606,232 shares and shared dispositive power over 2,737,752 shares, with no sole voting or dispositive power. The position is held through investment management affiliates, including SSGA Funds Management and various State Street Global Advisors entities, and is certified as being held in the ordinary course of business without the purpose of influencing control.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



STATE STREET CORPORATION
Signature:ELIZABETH SCHAEFER
Name/Title:SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER
Date:02/09/2026

FAQ

What does State Street Corporation report in its Schedule 13G for CareDx (CDNA)?

State Street Corporation reports a passive ownership stake in CareDx common stock. As of 12/31/2025, it beneficially owns 2,737,752 shares, representing 5.3% of the outstanding class, and files on Schedule 13G as an institutional investor holding the position in the ordinary course of business.

How many CareDx (CDNA) shares does State Street beneficially own and what percentage is this?

State Street beneficially owns 2,737,752 CareDx common shares, representing 5.3% of the class. This stake crosses the 5% threshold that triggers a Schedule 13G filing, indicating a significant but passive institutional ownership position in the company’s common stock.

What voting and dispositive powers does State Street have over its CareDx (CDNA) shares?

State Street reports no sole voting or dispositive power over CareDx shares. It has shared voting power over 2,606,232 shares and shared dispositive power over 2,737,752 shares, reflecting that these rights are exercised collectively through its affiliated investment manager entities.

Is State Street’s CareDx (CDNA) stake intended to influence control of the company?

State Street certifies that the CareDx shares were acquired and are held in the ordinary course of business. It states they were not acquired and are not held for the purpose of changing or influencing control of CareDx, aligning with the passive intent typical for Schedule 13G filings.

Which State Street affiliates are associated with the CareDx (CDNA) holdings?

The filing identifies several investment management subsidiaries linked to the CareDx position. These include SSGA Funds Management, Inc. and multiple State Street Global Advisors entities in the United States and Europe, which collectively manage the securities reported under State Street Corporation’s beneficial ownership.

Why did State Street file a Schedule 13G instead of a Schedule 13D for CareDx (CDNA)?

A Schedule 13G is used for passive holders that exceed 5% ownership without seeking control. State Street certifies the CareDx shares are held in the ordinary course of business and not to influence control, which fits the criteria for a Schedule 13G rather than a control-oriented Schedule 13D.
Caredx

NASDAQ:CDNA

CDNA Rankings

CDNA Latest News

CDNA Latest SEC Filings

CDNA Stock Data

943.79M
49.50M
3.43%
101.7%
12.97%
Diagnostics & Research
Services-medical Laboratories
Link
United States
BRISBANE